As African officials look for ways to slow a sharp drop in health assistance, they predict an impact of 2 million to 4 million deaths per year.
The test the US Centers for Disease Control and Prevention uses to identify clade I mpox cases is 'most likely not reliable' for detection of the substrain identified in the study, the authors say.
Another mpox study today showed that dose-sparing vaccine administration of the Jynneos vaccine appeared to have worked.
Receive the latest infectious disease information.
The agreement, using a new emergency funding mechanism, would secure 500,000 doses for delivery in 2024.
Also, the UK details its response plan that includes shoring up vaccine supplies, and US officials spell out the country's mpox research agenda.
Most of the roughly 7,100 patients were prescribed tecovirimat for the treatment of lesions in sensitive areas, such as the anogenital region, and for pain.
In other developments, health officials have reported in utero spread of the virus and the first case of the year in North Africa.
In Burundi's worsening outbreak, kids younger than 15 are the most affected group, similar to the DR Congo.
The DRC's health ministry could begin deploying the vaccine, donated by the European Commission, this weekend.
The step paves the way for purchase and shipping, as other factors fall into place.
The agency made a similar request to vaccine companies earlier this month. Meanwhile, Kenya reported its third case, in a Nairobi resident who had been in Uganda.
Officials have deployed 72 epidemiologists to affected countries to get a better idea of where and how mpox is spreading.
No one who was vaccinated was hospitalized with the viral disease.
